American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 04-2001 | 12-2000 | 04-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 719 | -1,631 | -1,880 | N/A | -2,136 |
| Depreciation Amortization | 154 | 91 | 123 | 420 | 106 |
| Accounts receivable | -52 | 323 | -205 | N/A | -197 |
| Accounts payable and accrued liabilities | -156 | -389 | 140 | N/A | 394 |
| Other Working Capital | -1,285 | -739 | 398 | -210 | 710 |
| Other Operating Activity | 220 | 495 | 504 | -30 | 277 |
| Operating Cash Flow | $-400 | $-1,850 | $-920 | $180 | $-846 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -156 | -1,202 | -73 | -40 | -145 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -73 |
| Sale Of Investment | N/A | N/A | 407 | N/A | 571 |
| Other Investing Activity | 106 | 40 | -220 | -220 | -289 |
| Investing Cash Flow | $-50 | $-1,162 | $114 | $-260 | $64 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200 | 720 | N/A | N/A | N/A |
| Debt Repayment | -42 | -17 | -11 | N/A | -11 |
| Common Stock Issued | 235 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | 0 | -1 |
| Other Financing Activity | 0 | 2,332 | -125 | -6 | 1,870 |
| Financing Cash Flow | $393 | $3,035 | $-136 | $-6 | $1,858 |
| Beginning Cash Position | 288 | 265 | 1,207 | N/A | 131 |
| End Cash Position | 231 | 288 | 265 | N/A | 1,207 |
| Net Cash Flow | $-57 | $23 | $-942 | $-86 | $1,076 |
| Free Cash Flow | |||||
| Operating Cash Flow | -400 | -1,850 | -920 | 180 | -846 |
| Capital Expenditure | -156 | -1,202 | -73 | N/A | -145 |
| Free Cash Flow | -556 | -3,052 | -993 | 180 | -991 |